Revenue (Quarterly) Chart

View Revenue (Quarterly) for GRRMF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
November 30, 2025 744.91M
August 31, 2025 650.87M
May 31, 2025 667.07M
February 28, 2025 541.78M
November 30, 2024 618.84M
August 31, 2024 542.27M
May 31, 2024 542.58M
February 29, 2024 506.42M
November 30, 2023 582.36M
August 31, 2023 533.42M
May 31, 2023 541.37M
February 28, 2023 489.23M
November 30, 2022 527.63M
August 31, 2022 486.59M
May 31, 2022 480.22M
February 28, 2022 419.78M
November 30, 2021 505.48M
August 31, 2021 453.81M
May 31, 2021 452.50M
February 28, 2021 367.76M
November 30, 2020 475.13M
August 31, 2020 401.92M
May 31, 2020 397.02M
February 29, 2020 335.48M
November 30, 2019 406.87M
Date Value
August 31, 2019 401.85M
May 31, 2019 400.56M
February 28, 2019 351.10M
November 30, 2018 449.73M
August 31, 2018 411.41M
May 31, 2018 403.18M
February 28, 2018 352.04M
November 30, 2017 441.85M
August 31, 2017 381.90M
May 31, 2017 367.58M
February 28, 2017 321.18M
November 30, 2016 318.49M
August 31, 2016 391.26M
May 31, 2016 391.15M
February 29, 2016 350.07M
November 30, 2015 414.64M
August 31, 2015 382.36M
May 31, 2015 389.36M
February 28, 2015 354.93M
November 30, 2014 422.73M
August 31, 2014 436.74M
May 31, 2014 462.54M
February 28, 2014 406.41M
November 30, 2013 438.98M
August 31, 2013 418.00M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Sartorius AG 1.060B
SCHOTT Pharma AG & Co. KGaA 327.61M
Agilent Technologies, Inc. 1.835B
Bio-Rad Laboratories, Inc. 651.00M
Bruker Corp. 838.50M